BVI (Beaver-Visitec International), a developer, manufacturer, and marketer of specialized surgical devices and custom procedure packs for the ophthalmic marketplace, signed a definitive agreement to acquire PhysIOL Group SA, a Belgium-based ophthalmic company specializing in the research, development, and manufacture of intraocular lenses (IOLs), from TA Associates.
The transaction, which was backed by TPG Capital, will allow BVI to expand its portfolio.
The financial terms of the deal were not disclosed.
Founded in 1986 at the University of Liège, PhysIOL offers a broad portfolio of innovative IOLs for cataract treatment. The company’s portfolio covers the full range of lenses, from traditional monofocal to premium trifocal. In addition to IOLs, PhysIOL offers a suite of related ophthalmic products, including phaco equipment and surgery consumables.
The company’s products are used by surgeons in more than 60 countries across the globe.